SMTL ID : 8bxh.1

Crystal structure of JAK2 JH1 in complex with momelotinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.30 Å

Oligo State

monomer

Ligands

1 x C87: Momelotinib(Non-covalent)

C87.1: 20 residues within 4Å: Chain A: L.39, G.40, G.42, G.45, S.46, V.47, A.64, K.66, V.95, M.113, E.114, Y.115, L.116, P.117, G.119, D.123, K.127, L.167, G.177, D.178 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.39, A:L.39, A:L.39, A:V.47, A:V.47, A:A.64, A:Y.115, A:L.167 Hydrogen bonds: A:G.42, A:G.45, A:L.116, A:L.116, A:K.127, A:D.178 Water bridges: A:K.66

1 x MLI: MALONATE ION(Non-functional Binders)

MLI.2: 3 residues within 4Å: Chain A: Q.90, Y.150, K.154 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Y.150 Hydrogen bonds: A:Y.150, A:Y.150 Water bridges: A:Q.90, A:K.154 Salt bridges: A:K.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miao, Y. et al., Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity. J.Med.Chem. (2024)

Release Date

2023-12-20

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence